![]() |
|
|
3 Section of Nutrition, Department of Pediatrics, and 4 Department of Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, CO 80262; 5 Center for Studies of Sensory Impairments, Aging, and Metabolism, Zona 11 (interior), Guatemala City, Guatemala, 01011; and 6 USDA, Agricultural Research Service, Aberdeen, ID 83210
* To whom correspondence should be addressed. E-mail: michael.hambidge{at}uchsc.edu.
| ABSTRACT |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The objectives of this study were to measure endogenous fecal Zn (EFZ) in school-aged children while consuming their habitual high-maize diet and, as part of a study previously reported (6), to also measure EFZ in children from the same poor Guatemalan village when fed a low-phytate maize.
| Methods |
|---|
|
|
|---|
Subjects. Sixty children (29 males and 31 females) aged (mean ± SD) of 8.9 ± 1.3 y participated in this study. Intravenous isotope administration was incomplete in 1 subject and 6 subjects reported incomplete metabolic sample collections.
Ethics. The study was approved by the Center for Studies of Sensory Impairments, Aging, and Metabolism Human Subjects Committee and by the Colorado Multiple Institutional Review Board. The consent form was written in Spanish and explained both in Spanish and Kaqchikel, the local ethnic language, with the support of resident health workers in Buena Vista. The study was initially described in information group sessions to anyone in the community who was potentially interested in having their family participate. After adequate time for consideration, interested families returned for further discussion and, if they elected to participate, to give written informed consent.
Diet. Participants and their families were free-living during the 10-wk study period. They consumed their habitual diets, the only exception being that their usual maize supply was replaced by maize provided by the investigators. Families were randomized to receive a low-phytate maize, the isohybrid wild type to this low phytate maize, or a locally grown control maize. The phytate intakes were (mean ± SD) 1536 ± 563 mg/d for the lpa11 low phytate group, 2056 ± 517 mg/d for the wild-type control, and 2253 ± 687 mg/d for the local maize control groups (6). Corresponding figures for phytate:Zn molar ratios were 18 ± 5, 26 ± 6, and 23 ± 5, respectively (6).
Isotope preparation. Accurately weighed quantities of preparations of Zn oxide enriched with 67Zn (Trace Sciences International) were dissolved in 0.5mol/L H2SO4 to prepare a stock solution. The pH of the stock solution was adjusted to 6.0 with ammonium hydroxide and the stock solution was diluted with sterile isotonic sodium chloride to a Zn concentration of 1.5 mmol/L. The solution was filtered through a 0.2-µm filter. The Zn concentrations were measured by atomic absorption spectrophotometry with mass correction factor applied (7). Accurately weighed quantities were stored in sealed sterile vials and tested for pyrogens and sterility before use.
Isotope administration.
After 8 wk of consumption of the low-phytate or 1 of the control maize varieties, EFZ was measured using an isotope dilution technique (8). An accurately weighed quantity (
0.800 mg) of 67Zn (90.9% purity) was administered i.v. during the afternoon on d 1. Administration was performed with a 10-mL syringe and 3-way stopcock via a scalp vein needle inserted into a superficial forearm vein over a 510-min interval. The syringe was flushed twice with normal saline using the 3-way stopcock.
Fecal markers. Nonabsorbable fecal markers (methylene blue, AKA brilliant blue, 1 mg/kg body wt, Warner Jenkinson) were administered with breakfast on d 3 and d 7 to demarcate the metabolic period.
Sample collection. All fecal samples from the time of the first administration of the fecal marker on d 3 until complete passage of the marker administered on d 7 were quantitatively collected in trace-metal free plastic bags. Timed spot (2050 mL) urine samples were collected once in the morning and once in the evening from d 3 to 7. Urine and fecal samples were kept frozen at 20°C until they were transported to University of Colorado Health Sciences Center for further processing and analyses.
Laboratory analyses.
Fecal samples were homogenized using a 1:1 ratio of water and duplicate aliquots (each
10% of total sample) were further processed for total and isotopic Zn analyses. Fecal samples were wet digested and dry ashed prior to reconstitution in 0.1 mol/L HCl for total Zn analyses. Total Zn in the digested samples was determined by flame atomic absorption spectrophotometry. The Zn in the reconstituted fecal samples was separated from other inorganic constituents by column chromatography. Urine samples were wet digested and dry ashed prior to removing the Zn by a chelation and extraction method (9).
The ratio for 67Zn:66Zn was measured in the purified fecal and urine samples using inductively coupled plasma-mass spectrometry (ICP-MS) (9). Isotope ratios were converted to percentage enrichment (defined to be all Zn in the sample from an isotopically enriched source divided by the total amount of Zn in the sample) by an algorithm that takes into account the isotope abundances and atomic mass of both the natural and the isotopically enriched Zn contained in the samples (L. Miller, unpublished data). In general, enrichment levels in the urine and fecal samples were >50-fold above the detection limit of the analytical method.
Data processing.
EFZ was calculated by an isotope dilution technique first described by Weigand and Kirchgessner (10) including the use of urine enrichment data and was subsequently first utilized in a human study by Jackson et al. (11). This involved the following formula:
![]() |
f is the corresponding fecal percent enrichment (%E) 67Zn, u is mean urine %E 67Zn during metabolic period, and t is time of metabolic period (4 d).
The quantity of endogenous Zn excreted in the feces when the quantity of Zn absorbed matches physiologic requirements (termed EFZPR) has been determined by the Dietary Reference Intakes Committee of the Food and Nutrition Board, National Institute of Medicine (5).
Data analysis.
Data were analyzed using GraphPad Prism version 4.00 for Windows (GraphPad Software, www.graphpad.com). Group data are reported as means ± SD and were compared by ANOVA using an
of 0.05. Pearson's correlation was used to determine the degree and significance of association between EFZ and total absorbed Zn (TAZ). The TAZ data were reported previously (6).
| Results |
|---|
|
|
|---|
|
| Discussion |
|---|
|
|
|---|
Because EFZ is not a constant but typically varies with TAZ, caution is required in comparing EFZ for different populations or for different pathophysiologic circumstances. The value of EFZ of special significance is EFZPR (1,5). Because, in this case, there was a zero slope for EFZ vs. TAZ, this value was the same as the mean measured value of EFZ. This does not apply, however, to other available data sets (1,5).
In evaluating these results, there are only very limited data with which comparison can be made. Two other data sets are available from less-developed countries; in Malawi, for children aged 96 m and weighing 22.1 kg, EFZPR was 1.45 mg Zn/d or 65 µg Zn·kg1·d1 (12,13). In rural southeast China, children aged 23 m and weighing 10.9 kg (14) had a calculated EFZPR of 0.8 mg Zn/d or 73 µg Zn·kg1·d1, i.e. quite close to the current results. There are no corresponding data from countries in which children of this age are considered to be well nourished. The Food and Nutrition Board, Institute of Medicine, elected to estimate EFZPR for children on a body wt basis. Relying on extrapolation from adult data, a value of 34 µg Zn·kg1·d1 was assigned for every childhood age group (5). On this basis, the EFZPR was high for each of these 3 studies of children in less-developed countries.
Zn absorption is a saturable process and age-related differences in the parameters of saturation response analysis of TAZ vs. ingested Zn are closely related to the length of the small intestine (15). Given the typically positive correlation between EFZ and TAZ, we estimated EFZPR for these childhood data adjusting for the difference between the length of the small intestine for the childhood age and that for adults (16) (Table 2). In contrast to expressing these EFZPR data as a function of body wt, when data are adjusted for differences in length of the small intestine compared with that of adults, the childhood data are lower rather than higher than adult data for each group of children.
|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Author disclosures: K. M. Hambidge, M. Mazariegos, N. W. Solomons, J. E. Westcott, S. Lei, V. Raboy, G. Grunwald, L. V. Miller, X. Sheng, and N. F. Krebs, no conflicts of interest. ![]()
7 Abbreviations used: EFZ, endogenous fecal zinc; EFZPR, EFZ at the level of absorption that matches the physiologic requirement; TAZ, total absorbed zinc; Zn, zinc. ![]()
Manuscript received 6 February 2007. Initial review completed 7 March 2007. Revision accepted 7 May 2007.
| LITERATURE CITED |
|---|
|
|
|---|
1. Hambidge KM, Krebs NF. Interrelationships of key variables of human zinc homeostasis: relevance to dietary zinc requirements. Annu Rev Nutr. 2001;21:42952.[Medline]
2. Krebs NF, Hambidge KM. Zinc metabolism and homeostasis: the application of tracer techniques to human zinc physiology. Biometals. 2001;14:397412.[Medline]
3. Krebs NF, Reidinger CJ, Miller LV, Hambidge KM. Zinc homeostasis in breast-fed infants. Pediatr Res. 1996;39:6615.[Medline]
4. Krebs NF, Westcott J. Zinc and breastfed infants: if and when is there a risk of deficiency? In: Davis MK, Isaacs CE, Hanson LA, Wright AL, editors. Integrating population outcomes, biological mechanisms and research methods in the study of human milk and lactation. New York: Kluwer Academic/Plenum Press; 2002. p. 6976.
5. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for vitamin a, vitamin k, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium and zinc. Washington: National Academy Press; 2001.
6. Mazariegos M, Hambidge KM, Krebs NF, Westcott JE, Lei S, Grunwald GK, Campos R, Barahona B, Raboy V, et al. Zinc absorption in Guatemalan schoolchildren fed normal or low-phytate maize. Am J Clin Nutr. 2006;83:5964.
7. Peirce PL, Hambidge KM, Goss CH, Miller LV, Fennessey PV. Fast atom bombardment mass spectrometry for the determination of zinc stable isotopes in biological samples. Anal Chem. 1987;59:20347.[Medline]
8. Krebs NF, Reidinger C, Westcott JE, Miller LV, Fennessey PV, Hambidge KM. Stable isotope studies of zinc metabolism in infants. Boca Raton: CRC Press; 1995.
9. Hambidge KM, Huffer JW, Raboy V, Grunwald GK, Westcott JL, Sian L, Miller LV, Dorsch JA, Krebs NF. Zinc absorption from low-phytate hybrids of maize and their wild-type isohybrids. Am J Clin Nutr. 2004;79:10539.
10. Weigand E, Kirchgessner M. 65Zn-labeled tissue zinc for determination of endogenous fecal zinc excretion in growing rats. Nutr Metab. 1976;20:31420.[Medline]
11. Jackson MJ, Jones DA, Edwards RH, Swainbank IG, Coleman ML. Zinc homeostasis in man: studies using a new stable isotope-dilution technique. Br J Nutr. 1984;51:199208.[Medline]
12. Hambidge M. Underwood Memorial Lecture: human zinc homeostasis: good but not perfect. J Nutr. 2003;133:S143842.
13. Manary MJ, Hotz C, Krebs NF, Gibson RS, Westcott JE, Arnold T, Broadhead RL, Hambidge KM. Dietary phytate reduction improves zinc absorption in Malawian children recovering from tuberculosis but not in well children. J Nutr. 2000;130:295964.
14. Sheng XY, Hambidge KM, Zhu XX, Ni JX, Krebs NF, Shen XM, Westcott JE, Lei S, Miller LV, et al. Zinc homeostasis and requirements in Chinese toddlers. Am J Clin Nutr. 2006;84:38994.
15. Hambidge KM, Krebs NF, Westcott JE, Miller LV. Changes in zinc absorption during development. J Pediatr. 2006;149:S648.[Medline]
16. Weaver LT, Austin S, Cole TJ. Small intestinal length: a factor essential for gut adaptation. Gut. 1991;32:13213.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||